Etoperidone is an atypical antidepressant introduced in Europe in 1977. It is a phenylpiperazine-substituted triazole derivative with a composition that classifies it as an analog of tradozone and presents a similar pharmacological profile. Etoperidone was developed by Angelini Francesco ACRAF. Its therapeutic use is listed as antidepressants. The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include Etoperidona and Etoperidonum. Its PubChem CID is 40589.
Etoperidone
| CAS No | 52942-31-1 |
|---|---|
| Molecular Formula | C19H28ClN5O |
| Molecular Weight | 377.9 g/mol |
| Synonyms | 2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-4,5-diethyl-1,2,4-triazol-3-one |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Etoperidone is an atypical antidepressant introduced in Europe in 1977. It is a phenylpiperazine-substituted triazole derivative with a composition that classifies it as an analog of tradozone and presents a similar pharmacological profile.
The listed CAS number is 52942-31-1.
The listed molecular formula is C19H28ClN5O.
The listed molecular weight is 377.9 g/mol.
2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-4,5-diethyl-1,2,4-triazol-3-one.
The source lists Etoperidona and Etoperidonum.